Recombinant Human Kinocilin (KNCN), also known as kinocilin, is a protein that has been studied for its potential roles in various biological processes. Despite its relatively recent emergence in scientific literature, KNCN has garnered interest due to its unique characteristics and potential applications in research and medicine. This article aims to provide a comprehensive overview of Recombinant Human Kinocilin (KNCN), including its definition, research findings, and potential applications.
Kinocilin is encoded by the gene symbol KNCN, which is also known as Kino or L5. The gene ID for KNCN is 148930, and its ORF size is approximately 228 bp . The protein structure and function of KNCN are not extensively detailed in current literature, suggesting a need for further research to understand its biological roles.
While specific applications of Recombinant Human Kinocilin (KNCN) are not well-documented, its availability in recombinant form and as part of over-expression systems suggests potential uses in:
Basic Research: Studying the biological functions of KNCN in cell culture models.
Gene Therapy: Using AAV vectors to introduce KNCN into cells for therapeutic purposes.
Protein-Protein Interaction Studies: Investigating how KNCN interacts with other proteins to understand its role in cellular processes.
Given the limited specific data available on Recombinant Human Kinocilin (KNCN), the following table summarizes general information about the protein and its resources:
| Category | Description |
|---|---|
| Gene Symbol | KNCN |
| Gene Name | kinocilin |
| Gene ID | 148930 |
| ORF Size | 228 bp |
| RefSeq# | BC101295 |
| HGNC ID | HGNC:26488 |
| Vector Availability | AAV vectors for over-expression |
Kinocilin may play a role in stabilizing dense microtubular networks and/or in vesicular trafficking.